Affected Products
Soltive Premium Superpulsed Laser System
The manufacturer, Gyrus Acmi Inc., received complaints about loss of kidney function after lithotripsy procedures involving the subject device. Through a clinical investigation and consultation with medical professionals, the events were potentially the result of knowledge-based failure where the user accustomed to using a different laser (Holmium:YAG) applied more energy than needed to achieve a certain outcome with the Soltive laser. Prior to these reported events, Olympus had planned for a software upgrade containing a new preset for ureteral stone. In light of this investigation, Olympus will expedite the distribution of the software upgrade as a preventative
measure. Additionally, the instruction for use will be updated to include additional verbiage regarding procedural differences between Holmium:YAG lasers and soltive lasers as it relates to device settings.